EcoDrugPlus

Ensembl ID : ENSUAMG00000021240
Gene Symbol: -
Cross references: -
139 Possible Orthologues:

Ensembl ID : ENSUAMG00000023229
Gene Symbol: -
Cross references: -
80 Possible Orthologues:

Ensembl ID : ENSUAMG00000023055
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSUAMG00000003665
Gene Symbol: -
Cross references: -
165 Possible Orthologues:

Ensembl ID : ENSUAMG00000003369
Gene Symbol: -
Cross references: -
76 Possible Orthologues:

Ensembl ID : ENSUAMG00000002240
Gene Symbol: -
Cross references: -
68 Possible Orthologues:

Ensembl ID : ENSUAMG00000001672
Gene Symbol: -
Cross references: -
249 Possible Orthologues:

Ensembl ID : ENSUAMG00000001352
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSUAMG00000024317
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSUAMG00000014612
Gene Symbol: -
Cross references: -
32 Possible Orthologues:

Ensembl ID : ENSUAMG00000023897
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSUAMG00000024318
Gene Symbol: -
Cross references: -
234 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).